Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

STRYKER CORPORATION

(SYK)
  Report
Delayed Nyse  -  04:03 2022-12-06 pm EST
235.54 USD   -0.99%
12/02Barclays Adjusts Price Target on Stryker to $257 From $239, Maintains Overweight Rating
MT
12/01Transcript : Stryker Corporation Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Dec-01-2022 08:50 AM
CI
11/15Stryker Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Stryker Launches Q Guidance System with Spine Guidance Software

09/27/2022 | 08:45am EST

Stryker announced the launch of its Q Guidance System for spine applications. The System combines new optical tracking options provided by a redesigned, camera with sophisticated algorithms of the newly launched Spine Guidance Software to deliver more surgical planning and navigation capability than ever before. When used with the Q Guidance System, the Spine Guidance Software is intended as a planning and intraoperative guidance system to enable open or percutaneous computer-assisted surgery and is the first spine navigation software to receive FDA clearance for use with pediatric patients aged 13 and older.

Q Guidance offers surgeons numerous benefits, including: A proprietary camera: The Q Guidance System features a 4th generation FP8000 camera that offers unmatched speeds and the flexibility of multiple optical tracking methods, including full-spectrum active/passive hybrid optical tracking. It is the only guidance system with proprietary active technology and a non-invasive patient tracker, SpineMask; Image processing: Spine Guidance Software features completely redesigned applications, semi-automatic and automatic processing features, gesture recognition, and broad compatibility with various types of image sets; Spine Guidance Software: Spine Guidance Software is designed to help surgeons optimize their workflow, minimize their time in the OR and address complex clinical decisions and techniques intraoperatively. Its computational power is designed to support spine product and software roadmap.

It is company's intention to develop and release new technologies within the Q ecosystem.


ę S&P Capital IQ 2022
All news about STRYKER CORPORATION
12/02Barclays Adjusts Price Target on Stryker to $257 From $239, Maintains Overweight Rating
MT
12/01Transcript : Stryker Corporation Presents at 5th Annual Evercore ISI HealthCO..
CI
11/15Stryker Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial ..
AQ
11/14Stryker opens the OR of the Future for customers to experience tomorrow's OR today
PR
11/14Stryker Opens the OR of the Future for Customers to Experience Tomorrow's OR
CI
11/04Insider Sell: Stryker
MT
11/03Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
GL
11/02DA Davidson Adjusts Stryker Price Target to $250 From $260, Maintains Buy Rating
MT
11/01Uber, Pfizer rise; Catalent, Stryker fall
AQ
11/01STRYKER CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
More news
Analyst Recommendations on STRYKER CORPORATION
More recommendations
Financials (USD)
Sales 2022 18 201 M - -
Net income 2022 2 568 M - -
Net Debt 2022 10 484 M - -
P/E ratio 2022 34,5x
Yield 2022 1,18%
Capitalization 89 135 M 89 135 M -
EV / Sales 2022 5,47x
EV / Sales 2023 5,08x
Nbr of Employees 46 000
Free-Float 98,2%
Chart STRYKER CORPORATION
Duration : Period :
Stryker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRYKER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Last Close Price 235,54 $
Average target price 237,67 $
Spread / Average Target 0,90%
EPS Revisions
Managers and Directors
Kevin A. Lobo Chairman, President & Chief Executive Officer
Glenn S. Boehnlein Chief Financial Officer & Vice President
Alan Douville Chief Information Officer & Vice President
Dana S. McMahon Chief Compliance Officer & Vice President
Howard E. Cox Director-Emeritus
Sector and Competitors
1st jan.Capi. (M$)
STRYKER CORPORATION-11.92%89 135
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.-1.14%16 398
SMITH & NEPHEW PLC-17.12%11 408
INSPIRE MEDICAL SYSTEMS, INC.0.37%6 672
AXONICS, INC.17.02%3 246
ENOVIS CORPORATION-30.89%2 959